Ramon Biosca Email & Phone Number

San Francisco Bay Area

Emeryville, California, United States

In December 2020 I was appointed to this position to develop and implement the contract manufacturing business model and lead the Business Development team.• Increased manufacturing volume by 15% and sales by 25% between 2019 and 2020 following a targeted activation marketing campaign and a real-time analysis of CDMO competitors.• First-year sales of $4 million doubled in the next year as a direct result of demonstrating the value of the transparency approach to the CDMO activities as opposed to the competitor's black box model.• +$18M in revenues between 2019-2021• Develop and implement a new marketing campaign based on CHIRON’s legacy brand name to capture new clients.• Develop and implement CDMO Readiness program to adequate regular production to the CDMO Business model.• Expand product portfolio to enzymes and vaccines for pharmaceutical companies.

Emeryville, California

In January 2014 Grifols acquired Novartis Dx Division based in Emeryville, California; and in September 2014 I was appointed to this position. A challenging and great opportunity to continue developing the biotech business. As GM and Site Leader, I provided leadership to Emeryville Diagnostic Industrial Group by guiding short-term and long-term strategies and projects for the Emeryville site, coordinating the operational processes and interdependencies between Quality and Tech Operations to align with the overall company vision, and prioritization processes in support of the product pipeline.Operational Budget: $50M/year Direct Reposts: 12 Headcount: 270CAPEX: +$6M/year Production Sales: $175M/year• Manage production of immunodiagnostics products (recombinant proteins and peptides).• Active interaction with Global R&D, HR, Finance, Global Marketing and (external) joint business partners.• Communicate a clear Industrial Diagnostics vision and strategy and ensure that these are reflected in focused and responsive initiatives within the global function.• 30% manufacturing cost reduction between 2015-2016, based on productivity and efficiency programs.• SAP implementation by 2016.• Cost-controlling program under SAP implemented by 2017.• BOM’s and routings for all manufacturing processes implemented by 2017.• New Pilot Plant fully functional by 2019 and Mammalian Cell Culture facility by 2022.

Los Angeles, Ca

Following the experience of managing a Grifols subsidiary in Australia, I was promoted to this position in the US and personally, a great opportunity to live and work in this country.Operational Budget: $9M Direct Reports: 5 Headcount: 90CAPEX: $1M/year Commercial Sales: $30MAreas of management:• Lead, manage and develop the overall performance of the Division.• Guide the strategic process improvements identifying “best practices” to streamline operations, gain efficiencies and ensure project prioritization process.• Achieve a culture of high performance and trust. Build an effective organizational structure that supports existing and future customers.• Drive Integrity & Compliance initiatives, and actively create a culture of Diversity & Inclusion.Achievements:• Develop and implement a new Service/Maintenance program (25% increased revenue).• Additional contracts/sales with consolidated Lab/Testing companies ($9M value/year)• Double digit growth in sales by end 2013.• 100% OTIF for orders and service.

Melbourne, Australia

In this position my main goal was to improve efficiency and increasing departmental profits while managing the company's overall operations.I managed diverse business elements including hiring staff, operating budgets, and overall responsibilities for safety, production, quality, and maintenance.Operational Budget: $10M Direct Reports: 10 Headcount: 70CAPEX: $4M Commercial Sales: $30MAchievements:• Total production increased 20% by end 2011.• Commercial sales increased 15% by end 2011 with double digit gross profit.• New contract with Australian Red Cross for ABO typing testing with $5M value/year.

Lachen, Schwyz, Switzerland

Responsible for the main areas of development and product life-cycle management for PCC's (Prothrombin Complex Concentrate), Biopharmaceutical Plasmas for Transfusion, Albumin and Antithrombin III.Coordinator of the DUMAS Project.This project enables to our partners to find even more effective ways of using their blood components therapies, thereby optimising safety and reducing costs simultaneously.

Barcelona, Catalonia, Spain

Responsible, as Group Product Manager, for Sales & Marketing development for the Immunohematology product line: DG Gel; accounting the following launches and extension product lines:DGel Cards International launchMove to 8! Branding campaignNew WADiana Compact relaunchNew manual instrumentation launchNew fully automated project

Before joining Ortho Clinical-Diagnostics, I was working as Technical Director of the HCV laboratory at the Hospital Clinic of Barcelona (Spain) for a couple of years where I had the opportunity to continue cultivating my passion for the ImmunoHeamatology / Serology field mainly in the Donor Screening segment.After that and due to my involvement in HCV (at that time non-A non B Hepatitis) studies, I held the following managing positions at Johnson & Johnson at the Ortho-Clinical Diagnostics division:Rep sales (North-Center Catalonia)Immunohematology Product SpecialistImmunohematology & Serology Product ManagerImmunohematology Business Unit ManagerIn 2022 I also had the opportunity to manage the commercial and marketing activities in the North-East Spain for LifeScan and its Diabetes product line: OneTouch.

Executive Development Program, International Business, 80 Academic Hours / Year 2017- 2018

"Challenging the Future" Executive Business Development Program Managing Disruptive Markets

Msc, Biochemistry & Immunology